Arjen Joosse

Dr. Arjen Joosse is a Researcher at the Department of Medical Oncology, Erasmus MC, Erasmus University Rotterdam. His research focuses on immunotherapy applications in oncology, particularly immune checkpoint inhibitors (ICIs) in melanoma and metastatic cancers. Key areas include ICI-induced adverse events, brain metastasis progression, and cardiovascular effects of immunotherapy. He collaborates on interdisciplinary studies involving critical care, neuro-oncology, and patient-reported outcomes.

His work spans systematic reviews, clinical trials, and observational studies, addressing both therapeutic efficacy and quality-of-life dimensions. Notable contributions include analyzing ICU admissions in ICI-treated patients and investigating atherosclerosis onset in melanoma therapy contexts.